Zobrazeno 1 - 10
of 340
pro vyhledávání: '"Kathleen M. Fox"'
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background In end-stage kidney disease, patients may undergo parathyroidectomy if secondary hyperparathyroidism cannot be managed medically. This study was designed to estimate the parathyroidectomy rate in the United States (US) and to quan
Externí odkaz:
https://doaj.org/article/872e0992f3d649f8a412d10ff022bc82
Autor:
Angelo Karaboyas, Daniel Muenz, Yunji Hwang, William Goodman, Sunfa Cheng, Pooja Desai, Kathleen M. Fox, Bruce M. Robinson, Ronald L. Pisoni
Publikováno v:
Kidney Medicine, Vol 4, Iss 6, Pp 100475- (2022)
Rationale & Objective: Some US hemodialysis (HD) facilities switched from oral cinacalcet to intravenous etelcalcetide as the primary calcimimetic therapy to control parathyroid hormone (PTH) levels after the introduction of etelcalcetide in 2017. Al
Externí odkaz:
https://doaj.org/article/a9eb60af74304f408e1dbccff9045764
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in Korea. According to a report of published by Statistics Korea in 2014, cerebrovascular disease and cardiovascular disease were the major/leading cause
Externí odkaz:
https://doaj.org/article/47de6d83d8e44bb1a35183f9cff78113
Autor:
Jeffrey R. Curtis, Kathleen M. Fox, Fenglong Xie, Yujie Su, David Collier, Cassie Clinton, Hafiz Oko-osi
Publikováno v:
Rheumatology and Therapy. 9:1329-1345
In patients with rheumatoid arthritis (RA), attaining remission or low disease activity (LDA), as recommended by the treat-to-target approach, has shown to yield improvement in symptoms and quality of life. However, limited evidence from real-world s
Autor:
John Mark Stephens, Kathleen M. Fox, Pooja Desai, Sunfa Cheng, William G. Goodman, Jessica B. Kendrick
Publikováno v:
Hemodialysis International. 26:243-254
This study described control of parathyroid hormone (PTH), phosphorus, and corrected calcium in adults initiating calcimimetics in small dialysis organizations after the introduction of etelcalcetide.This retrospective study using Visonex Clarity ele
Autor:
Paul Telfer, Irene Agodoa, Kathleen M. Fox, Laurie Burke, Timothy Mant, Marzena Jurek, Margaret Tonda, Josh Lehrer-Graiwer
Publikováno v:
Hematology Reports, Vol 10, Iss 2 (2018)
For many patients with sickle cell disease (SCD), jaundice is a significant clinical disease manifestation that impacts on patient well-being. We report a case of a patient with SCD and chronic jaundice treated with voxelotor (GBT440), a novel small
Externí odkaz:
https://doaj.org/article/5a6a888f058a4f77855c543547925246
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 12 (2018)
Background: Randomized clinical trials have shown long-acting mono bronchodilator therapy to be efficacious in improving lung function and dyspnea, while reducing exacerbations; however, less is known regarding the effectiveness in routine clinical p
Externí odkaz:
https://doaj.org/article/296504c697584f2cb6d1bf1c86325987
Publikováno v:
Cancer. 127:3457-3465
Background The US Food and Drug Administration has recently approved a number of new cancer drugs. The clinical trials that serve as the basis for new cancer drug approvals may not reflect how the drugs will perform in routine practice and do not mea
Autor:
Titas Buksnys, Nigel Armstrong, Steve Ryder, Elena Castro, Kathleen M. Fox, Janine Ross, Carol A. Forbes, R.G.W. Quek
Publikováno v:
Future Oncology. 17:853-864
Background: Ongoing clinical trials are investigating poly(ADP-ribose) polymerase (PARP) inhibitors to target the DNA damage repair (DDR) pathway in prostate cancer. DDR mutation screening will guide treatment strategy and assess eligibility for clin
Autor:
Machaon Bonafede, Shravanthi R. Gandra, Stuart L. Silverman, Michele McDermott, Kathleen M. Fox, Oth Tran, Xiaoqing Xu
Publikováno v:
Osteoporosis International
Summary The study examined long-term direct and indirect economic burden of osteoporotic fractures among postmenopausal women. Healthcare costs among fracture patients were substantial in first year after fracture and remained higher than fracture-fr